Showing results (1751-1760 of 1,873) with videos related to
Sort By:
Pageof 188
Cancer Discovery|September 25, 2021
Smarca4 Inactivation Promotes Lineage-Specific Transformation and Early Metastatic Features in the LungCarla P Concepcion, Sai Ma, Lindsay M LaFave, et al.JCO Precision Oncology|November 20, 2025
Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine NeoplasmsRohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.Nature Communications|May 20, 2021
Nanostructure-specific X-ray tomography reveals myelin levels, integrity and axon orientations in mouse and human nervous tissueMarios Georgiadis, Aileen Schroeter, Zirui Gao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2012
Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancerCharles M Rudin, Christine L Hann, Edward B Garon, et al.Lancet (London, England)|December 17, 2023
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 studyChiaojung Jillian Tsai, Jonathan T Yang, Narek Shaverdian, et al.Antimicrobial Agents and Chemotherapy|February 8, 2017
Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?Steven Marshall, Andrea M Hujer, Laura J Rojas, et al.Cancer Research|November 24, 2021
Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line ChemotherapyAlvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yuan Hao, et al.Journal of Medicinal Chemistry|May 19, 2020
A γ-Lactam Siderophore Antibiotic Effective against Multidrug-Resistant Gram-Negative BacilliJoel A Goldberg, Ha Nguyen, Vijay Kumar, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2018
PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancersJ K Sabari, G C Leonardi, C A Shu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2026
The Genomic Landscape of MYC, MYCL, and MYCN Amplified Solid TumorsMatteo Repetto, Allison L Richards, Monica F Chen, et al.Pageof 188